RE:RE:RE:RE:RE:Don't sell your shares! Well Said Tech one.
And you are spot on in your take, particularly with Dialco, although I think your valuation is light by two thirds.
PMX and Baxter seem to be dominating the posts this week. It is easy to lose track of the recently COMMERCIAL Dialco division, and their own two pronged approach to the ownership of the in in-clinic/hospital and home dialysis market for years to come.
DIALCO the WHOLLY OWNED DIALYSIS DIVISION: FDA Approved, Cloud connected, touch screen controlled, cost effective, excellent safety profile, easy to use, instantaneous monitoring by client's physician, innovative, clean sheet design, intuitive, 10 year competitive regulatory lead, portable and set to absolutely hammer the competition!!!.... And it did with the very recent ARC Dialysis deal!
That is an oversight that is easy to make if you are a new or prospective investor.
If we had an attentive, non hibernating analyst Stockhouse would not be the only source of opinion on Spectral but such is the case.
Thanks again!